Researchers from IDIBAPS have coordinated a study in which they show the involvement of a molecule and a brain region in this process.
IDIBAPS publishes more than 300 scientific articles on the disease every year, which represent 22.5% of the total number of publications of the insti1
On 11 February, International Day of Women and Girls in Science, a new edition of the #100tífiques (100 female scientists) talks will be held, both i1
This analysis, the largest conducted to date and led by Hospital Clínic–IDIBAPS researchers, provides evidence of the inefficacy of this therapeutic1
Researchers from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the IIBB-CSIC-IDIBAPS have led the study, published in t1
The finding may make it possible to take therapeutic approaches that will increase the success rate of cognitive-behavioral therapy. This is the ther1
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
Researchers at Hospital Clínic-IDIBAPS are leading the CIBERESUCICOVID project, which seeks to identify the risk and prognosis factors of patients wi1
Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in t1
The study shows how the average life of the virus is drastically reduced, in transplanted patients and cell cultures alike.
